Tech Company Financing Transactions
Trace Genomics Funding Round
Trace Genomics, based in Burlingame, secured $4 million from Refactor Capital, Fall Line Capital and Illumina Ventures.
Transaction Overview
Company Name
Announced On
7/15/2016
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
849 Mitten Rd. 104
Burlingame, CA 94010
USA
Burlingame, CA 94010
USA
Phone
Website
Email Address
Overview
Our proprietary molecular assay for soil-borne pathogens enables affordable detection of hundreds of pathogens and beneficial organisms simultaneously. Our assay is based on genetic sequencing technology, enabling strain-specific identification and quantitation.
Management Team
Browse more venture capital transactions:
Prev: 7/15/2016: Phrasee venture capital transaction
Next: 7/15/2016: Iagnosis venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs